ARTICLE AUTHORS
ARTICLE INFO
Cite Score:
0.25
ELSEVIER SCOPUS

Evaluation of Asymptomatic Peripheral Arterial Disease by Ankle- Brachial Index in Patients with Concomitant Coronary Arterial Disease

AUTHORS

Hosein Vakili 1 , Roxana Sadeghi 1 , * , Kobra Doustali 1 , Habibollah Saadat 1 , Mohammad Hasan Namazi 1 , Morteza Safi 1

AUTHORS INFORMATION

1 Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

How to Cite: Vakili H , Sadeghi R , Doustali K , Saadat H , Namazi M H, et al. Evaluation of Asymptomatic Peripheral Arterial Disease by Ankle- Brachial Index in Patients with Concomitant Coronary Arterial Disease, Int Cardio Res J. 2017 ; 6(4):e12790.

ARTICLE INFORMATION

International Cardiovascular Research Journal: 6 (4); e12790
Published Online: December 31, 2012
Article Type: Brief Report
Received: May 09, 2017
Accepted: November 22, 2012

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Peripheral arterial disease is associated with adverse cardiovascular outcomes.
As such, it is found that screening for peripheral arterial disease (PAD) improves risk
assessment. Thus, intensive risk factor modification and medical treatment in these
patients are necessary.
Objectives: The purpose of this study was to determine the prevalence of asymptomatic
peripheral arterial disease in patients with concomitant coronary arterial disease.
Methods: Asymptomatic peripheral arterial disease was investigated in 400 patients (60%
males, 40% females, aged 59.7± 11.3) with a documented coronary arterial disease.
Results: Among patients with documented CAD, 12% had asymptomatic PAD with the
ABI ratio of less than 0.9.
Conclusions: It is advisable to screen for PAD not only as a disease but also as a risk
assessment method for atherosclerosis.

Keywords

Ankle-Brachial Index,Peripheral Arterial Disease,Coronary Artery,Asymptomatic

© 0, Shiraz University of Medical Sciences.

Fulltext

The full text is available in PDF.

References

  • 1. The references are available in PDF.
    • COMMENTS

    LEAVE A COMMENT HERE: